George Lawrence Mikan III - Dec 14, 2024 Form 4 Insider Report for NeueHealth, Inc. (NEUE)

Signature
/s/ Eric Halverson for George Lawrence Mikan III, Attorney-in-Fact
Stock symbol
NEUE
Transactions as of
Dec 14, 2024
Transactions value $
-$70,237
Form type
4
Date filed
12/18/2024, 09:15 PM
Previous filing
May 6, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEUE Common Stock Options Exercise +35K +53.99% 99.8K Dec 14, 2024 Direct F1
transaction NEUE Common Stock Sale -$70.2K -16.8K -16.83% $4.18 83K Dec 17, 2024 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEUE Restricted Stock Units Options Exercise $0 -35K -100% $0.00 0 Dec 14, 2024 Common Stock 35K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 These shares were sold by the reporting person to cover tax withholding obligations upon the vesting of restricted stock units and were not discretionary transactions by the reporting person.
F3 The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.99 to $4.60 per share. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 60% of the restricted stock units awarded vested on the 2nd anniversary of the grant date and 40% vested on the 3rd anniversary of the grant date.